MGX insider trading — Metagenomi Therapeutics, Inc.
Over the last 90 days, insiders at Metagenomi Therapeutics, Inc. (MGX) made 1 open-market purchase worth $23K and 3 open-market sales worth $5K, making them net buyers by $18K. The largest purchase was by Reid Laurence (Director), who bought 20,000 shares for $23K on Sep 9, 2026. The largest sale was by Irish Jian (See Remarks), who sold 2,140 shares for $2K on Sep 8, 2026.
Updated Oct 16, 2026.
Recent MGX insider transactions
Every Form 4 filed by Metagenomi Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Reid Laurence | Director | P · Purchase | Direct | 20,000 | $1.17 | $23K | Form 4 |
| Sep 8, 2026 | Wein Matthew | See Remarks | S · Sale | Direct | 358 | $1.16 | $415 | Form 4 |
| Sep 8, 2026 | Irish Jian | See Remarks | S · Sale | Direct | 2,140 | $1.16 | $2K | Form 4 |
| Sep 8, 2026 | Wapnick Pamela | Chief Financial Officer | S · Sale | Direct | 1,911 | $1.16 | $2K | Form 4 |
MGX insider trading FAQ
Are insiders buying MGX stock?
Yes. In the last 90 days, Metagenomi Therapeutics, Inc. insiders made 1 open-market purchase totaling $23K, and 3 open-market sales totaling $5K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading MGX?
Recent buyers: Reid Laurence. Recent sellers: Irish Jian, Wapnick Pamela, Wein Matthew.
Where does MGX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.